Beren Therapeutics's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q2 2026; the issues it reports most are Health Issues.

Beren Therapeutics

Latest quarter: $0; Q2 2026 · 1 reports
Last 12 months: $0; Last 1 quarters
vs last quarter: No record; Q2 2026 against the quarter before
First report: Q2 2026; The first quarter a report named it

Lobbying by quarter

No lobbying spend in this period.

Beren Therapeutics lobbying by quarter
Quarter	Amount	Reports
Q2 2026	$0	1

Policy issues the reports name

Health issues1 reports

A report that names several issues counts once for each.

Who was lobbied

HOUSE OF REPRESENTATIVES1 reports
SENATE1 reports

Firms it paid

Firm
Gridiron Public Affairs	$0	1 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

	Filed by		Issues
07/16for Q2	Gridiron Public Affairs	Under $5,000	Health issues
05/26for Q2	Gridiron Public Affairs	Under $5,000	Health issues